Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine wound catheter analgesia after neonatal abdominal surgery
ACTRN12617000398303Phase 3Terminated
- Sponsor
- The Children's Hospital at Westmead
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bupivacaine in postoperative pain (2 arms), sponsored by The Children's Hospital at Westmead. Primary endpoint: Cumulative intravenous opioid dose. Started Sep 2017; status: terminated.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12617000398303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000398303.